Naturopathic medicine and type 2 diabetes: A retrospective analysis from an academic clinic

Alternative Medicine Review

Volumn 11, Issue 1, 2006, Pages 30-39

  Bradley, Ryan ^b,d   Oberg, Erica B ^a,b,c  

^a Institute for Complementary Medicine   (United States)

^b BASTYR UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Bastyr Center for Natural Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CARNITINE; CHROMIUM; INSULIN; MAGNESIUM; OMEGA 3 FATTY ACID; ORAL ANTIDIABETIC AGENT; THIOCTIC ACID; UBIDECARENONE; VANADIUM;

ACCURACY; ALTERNATIVE MEDICINE; ARTICLE; CINNAMON; DIABETIC DIET; DIET SUPPLEMENTATION; EVIDENCE BASED MEDICINE; EXERCISE; FENUGREEK; GLYCEMIC CONTROL; GYMNEMA; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MEDICAL RECORD; MEDICAL SOCIETY; MOMORDICA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; PATIENT COUNSELING; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY; STRESS;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC DIET; DIETARY CARBOHYDRATES; DIETARY PROTEINS; HUMANS; HYPERGLYCEMIA; HYPERTENSION; LIPIDS; NATUROPATHY; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL;

EID: 33645780831     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-342.
2. Yeh GY, Eisenberg DM, Davis RB, Phillips RS. Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey. Am J Public Health 2002;92:1648-1652.
3. Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-932.
4. Boon HS, Cherkin DC, Erro J, et al. Practice patterns of naturopathic physicians: results from a random survey of licensed practitioners in two US States. BMC Complement Altern Med 2004;4:14.
5. American Diabetes Association Task Force for Writing Nutrition Principles and Recommendations for the Management of Diabetes and Related Complications. American Diabetes Association position statement: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. J Am Diet Assoc 2002;102:109-118.
6. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003;26:1277-1294.
7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005;28:990.
8. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412.
9. Khan A, Safdar M, Ali Khan MM, et al. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003;26:3215-3218.
10. Hodgson JM, Watts GF, Playford DA, et al. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr 2002;56:1137-1142.
11. Eriksson JG, Forsen TJ, Mortensen SA, Rohde M. The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus. Biofactors 1999;9:315-318.
12. Collins R, Armitage J, Parish S, et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005-2016.
13. Mikhail N, Cope D. The JNC-7 guidelines and the optimal target for systolic blood pressure. Hypertension 2004;43:e31.
14. Lipsy RJ. The National Cholesterol Education Program Adult Treatment Panel III guidelines. J Manag Care Pharm 2003;9:2-5.
15. Watts CA, Lafferty WE, Baden AC. The effect of mandating complementary and alternative medicine services on insurance benefits in Washington State. J Altern Complement Med 2004;10:1001-1008.
16. Williamson DF, Vinicor F, Bowman BA; Centers for Disease Control and Prevention Primary Prevention Working Group. Primary prevention of type 2 diabetes mellitus by lifestyle intervention: implications for health policy. Ann Intern Med 2004;140:951-957.
17. Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 2003;26:2518-2523.
18. Gohlke H. Lifestyle modification - is it worth it? Herz 2004;29:139-144. [Article in German]
19. Langsjoen PH, Langsjoen AM. The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications. Biofactors 2003;18:101-111.
20. Rundek T, Naini A, Sacco R, et al. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol 2004;61:889-892.
21. Polo V, Saibene A, Pontiroli AE. Nicotinamide improves insulin secretion and metabolic control in lean type 2 diabetic patients with secondary failure to sulphonylureas. Acta Diabetol 1998;35:61-64.
22. Putzer GJ, Ramirez AM, Sneed K, et al. Prevalence of patients with type 2 diabetes mellitus reaching the American Diabetes Association's target guidelines in a university primary care setting. South Med J 2004;97:145-148.
23. No authors listed. Aspirin therapy in diabetes. American Diabetes Association. Diabetes Care 1997;20:1772-1773.
24. Muhammad S. Epidemiology of diabetes and obesity in the United States. Compend Contin Educ Dent 2004;25:195-198,200,202.
25. Institute of Medicine. Complementary Medicine in the United States. Washington, DC: National Academy Press; 2005:337.